Michael D Tarantino Selected Research

romiplostim

12/2021	Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registry.
1/2021	Clinical overview and practical considerations for optimizing romiplostim therapy in patients with immune thrombocytopenia.
11/2020	Romiplostim treatment for children with immune thrombocytopenia: Results of an integrated database of five clinical trials.
11/2019	Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia.
7/2016	Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.
1/2015	Romiplostim as a treatment for immune thrombocytopenia: a review.
2/2008	Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael D Tarantino Research Topics

Disease

27	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2023 - 06/2003
19	Hemorrhage 11/2023 - 03/2006
11	Thrombocytopenia (Thrombopenia) 01/2023 - 06/2003
8	Hemophilia A (Haemophilia) 11/2023 - 06/2004
3	Thrombosis (Thrombus) 01/2022 - 12/2008
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2022 - 01/2021
2	Infections 01/2021 - 07/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2015 - 01/2014
2	Hemolysis 05/2012 - 06/2007
1	Type 1 von Willebrand Disease 11/2023
1	Pulmonary Embolism 01/2022
1	Hepatic Infarction 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Thrombophilia 01/2022
1	COVID-19 01/2021
1	Guillain-Barre Syndrome 01/2021
1	Thrombotic Thrombocytopenic Purpura 01/2020
1	Hemophilia B (Haemophilia B) 09/2019
1	Poisoning 01/2018
1	Disease Susceptibility (Diathesis) 01/2018
1	Thrombasthenia (Glanzmann Thrombasthenia) 01/2017
1	Thrombocytosis (Thrombocythemia) 07/2016
1	Headache (Headaches) 07/2016
1	Hematuria 07/2016
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2015
1	Disseminated Intravascular Coagulation 05/2012
1	Renal Insufficiency (Renal Failure) 05/2012
1	Thromboembolism 12/2008
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 06/2004
1	Rheumatoid Arthritis 06/2003

Drug/Important Bio-Agent (IBA)

18	Inosine Triphosphate (ITP)IBA 01/2023 - 06/2003
7	romiplostim FDA Link 12/2021 - 02/2008
6	eltrombopag FDA Link 01/2021 - 01/2012
4	Thrombopoietin ReceptorsIBA 01/2021 - 01/2014
3	Factor VIII (Coagulation Factor VIII)IBA 09/2023 - 01/2021
3	Blood Coagulation Factors (Coagulation Factor)IBA 07/2021 - 06/2004
3	RHO(D) antibody (anti-D)IBA 05/2012 - 04/2006
2	Neutralizing AntibodiesIBA 02/2022 - 12/2021
2	recombinant FVIIa (rFVIIa)FDA Link 02/2022 - 01/2017
2	eculizumab FDA Link 01/2022 - 01/2021
2	Antiphospholipid AntibodiesIBA 01/2022 - 01/2021
2	AntibodiesIBA 12/2021 - 07/2005
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 04/2006
2	Immunoglobulins (Immunoglobulin)IBA 05/2012 - 04/2006
1	von Willebrand FactorIBA 11/2023
1	simoctocog alfa (Nuwiq)IBA 11/2023
1	AutoantibodiesIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	avatrombopagIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2022
1	Anticardiolipin AntibodiesIBA 01/2022
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	factor VIII-Fc fusion proteinIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	VaccinesIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	emicizumabIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2020
1	fostamatinibIBA 01/2020
1	thiamine triphosphorate (TTP)IBA 01/2020
1	IsoantibodiesIBA 09/2019
1	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 01/2018
1	AnticoagulantsIBA 01/2018
1	bromfenacoum (Ratak)IBA 01/2018
1	Factor VII (Proconvertin)IBA 01/2017
1	Thrombopoietin (c-mpl Ligand)IBA 01/2015
1	Hemostatics (Antihemorrhagics)IBA 01/2014
1	AntithrombinsIBA 12/2008
1	bivalirudin (Angiomax)FDA Link 12/2008
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2008
1	Heparin (Liquaemin)FDA LinkGeneric 12/2008
1	Antinuclear AntibodiesIBA 07/2005
1	Etanercept (Enbrel)FDA Link 06/2003

Therapy/Procedure

6	Therapeutics 07/2021 - 01/2015
4	Drug Therapy (Chemotherapy) 01/2020 - 02/2004
3	Splenectomy 10/2022 - 06/2003
2	Plasma Exchange 01/2022 - 01/2021
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2021
1	Catheters 05/2019
1	Neonatal Intensive Care 01/2018
1	Cardiopulmonary Resuscitation (CPR) 01/2018
1	Critical Care (Surgical Intensive Care) 01/2017